Today: 7 February 2026
Subscribe

Nebius Group (NBIS) Stock Slides as AI “Neocloud” Volatility Returns: News, Forecasts and Analysis for Dec. 16, 2025

Nebius Group (NBIS) Stock Slides as AI “Neocloud” Volatility Returns: News, Forecasts and Analysis for Dec. 16, 2025

Nebius Group N.V. (NASDAQ: NBIS) shares were lower on Tuesday, December 16, 2025, extending a recent pullback that has split Wall Street into two camps: investors who see Nebius as a scarce, high-demand “AI infrastructure” winner, and skeptics who argue the stock’s fundamentals can’t yet justify the volatility and valuation. As of the latest trade Tuesday, NBIS was around $78.54, down about 3.2% on the day, with an intraday range of roughly $76.95 to $81.88 and volume near 9.5 million shares. That decline follows a sharp drop in the prior session: MarketBeat reported NBIS fell 7.5% on Monday to about
16 December 2025
··
EV Stocks Today: Tesla Near Record High on Driverless Robotaxi Tests as Ford’s $19.5B EV Reset and a Charging Lawsuit Jolt the Sector (Dec. 16, 2025)

EV Stocks Today: Tesla Near Record High on Driverless Robotaxi Tests as Ford’s $19.5B EV Reset and a Charging Lawsuit Jolt the Sector (Dec. 16, 2025)

Electric vehicle (EV) stocks are trading on a split screen Tuesday, December 16, 2025: Tesla is climbing toward record territory on fresh robotaxi momentum, while much of the broader EV ecosystem—from early-stage automakers to charging names—faces a tougher tape as investors digest a major Ford strategy pivot, policy uncertainty around charging buildouts, and rate-sensitive market moves following the delayed U.S. jobs report. Below is what matters most for EV stocks today in the U.S. stock market, as of ~1:45 PM ET (intraday), and what investors are watching next. EV stocks snapshot (U.S.-listed) around 1:45 PM ET Moves are intraday vs. the prior close and change quickly. Tesla
16 December 2025
···········
SoFi Stock (SOFI) News Today: $1.5B Share Offering Fallout, Analyst Targets, and 2026 Forecasts (Dec. 16, 2025)

SoFi Stock (SOFI) News Today: $1.5B Share Offering Fallout, Analyst Targets, and 2026 Forecasts (Dec. 16, 2025)

SoFi Technologies, Inc. (NASDAQ: SOFI) is back in focus on Tuesday, December 16, 2025, as investors weigh a December equity raise, fresh product rollouts, and a growing stack of mixed analyst calls heading into 2026. Shares traded around $26.16 in the latest data Tuesday, up about 1.3% from the prior close, after ranging between roughly $25.42 and $26.74 during the session. The stock remains about 20% below its $32.73 all-time high set on November 12, 2025, underscoring how quickly sentiment can swing in high-beta fintech names. TradingView Below is a detailed rundown of the key news, forecasts, and analyses circulating
16 December 2025
·
Home Depot Stock (NYSE: HD) Update on Dec. 16, 2025: Analyst Price Targets, 2026 Outlook, and the Headlines Moving Shares

Home Depot Stock (NYSE: HD) Update on Dec. 16, 2025: Analyst Price Targets, 2026 Outlook, and the Headlines Moving Shares

Home Depot, Inc. (The) stock (NYSE: HD) is back in focus on Tuesday, December 16, 2025, as investors weigh a fresh analyst price-target move, the company’s newly set preliminary fiscal 2026 outlook, and a cybersecurity headline that has kept risk watchers attentive. At midday, HD was trading in the mid-$350s, after a volatile stretch that began with management’s Investor and Analyst Conference last week and continued through a wave of analyst revisions. StockAnalysis+1 Below is a comprehensive roundup of today’s key HD stock news, current forecasts, and the most relevant analysis shaping sentiment on Dec. 16. Home Depot stock price
16 December 2025
Coca-Cola Stock (KO) News and Forecasts for Dec. 16, 2025: Analyst Targets, Dividend Outlook, and Key Catalysts

Coca-Cola Stock (KO) News and Forecasts for Dec. 16, 2025: Analyst Targets, Dividend Outlook, and Key Catalysts

Coca-Cola stock (NYSE: KO) is trading near $70.84 on Tuesday, Dec. 16, 2025, down modestly on the session (about -0.18% as of the early afternoon timestamp shown by StockAnalysis). The day’s range has been tight—roughly $71.30 at the high and $70.54 at the low—reflecting the defensive, lower-volatility profile investors typically associate with the beverage giant. StockAnalysis While there’s no single “earnings-style” headline hitting today, KO is in the middle of several market narratives that matter for 2026 positioning: leadership transitions across consumer staples, continued focus on profitability via bottler refranchising, and the ever-present debate over whether Coca-Cola’s premium valuation is
16 December 2025
Globalstar (GSAT) Stock News on Dec. 16, 2025: Deutsche Bank Starts Coverage, Skydio Drone Trial, and Updated Analyst Forecasts

Globalstar (GSAT) Stock News on Dec. 16, 2025: Deutsche Bank Starts Coverage, Skydio Drone Trial, and Updated Analyst Forecasts

Globalstar, Inc. stock (NASDAQ: GSAT) traded sharply lower on Tuesday, December 16, 2025, despite fresh operational news highlighting its licensed spectrum and private 5G ambitions. Shares were down about 8.5% at $63.20 in the latest trading update (after opening near $67.75 and swinging between $69.05 and $62.84), underscoring how sensitive GSAT has become to valuation and “what’s next” narratives after a huge run in 2025. Two developments dominated today’s headlines: Together, those updates paint a very 2025 kind of investing picture: the technology story keeps getting stronger, while the “price you pay for the story” is where the fight breaks
16 December 2025
Corcept Therapeutics (CORT) Stock Drops on Dec. 16, 2025: UBS Neutral Call, Relacorilant FDA Catalyst, and Updated Price Targets

Corcept Therapeutics (CORT) Stock Drops on Dec. 16, 2025: UBS Neutral Call, Relacorilant FDA Catalyst, and Updated Price Targets

Corcept Therapeutics Incorporated (NASDAQ: CORT) ended Tuesday, December 16, 2025, sharply lower after a strong 2025 run that had pushed expectations—and valuation—into the spotlight. Shares closed at $79.44, down $7.86 (about 9%) from the prior close, after trading as low as $78.84 on the day. The day’s narrative around Corcept Therapeutics stock wasn’t driven by a single blockbuster headline like an FDA decision or a clinical-trial halt. Instead, it was a classic “high-expectations” session: fresh sell-side coverage, valuation-focused commentary, and investors recalibrating risk ahead of a major FDA catalyst for relacorilant later this month. Below is a complete roundup of
16 December 2025
···
PBF Energy Stock Slides on Refinery Headlines: Today’s News, Analyst Forecasts, and Outlook for NYSE:PBF (December 16, 2025)

PBF Energy Stock Slides on Refinery Headlines: Today’s News, Analyst Forecasts, and Outlook for NYSE:PBF (December 16, 2025)

PBF Energy Inc. stock (NYSE:PBF) is having a rough session on Tuesday, December 16, 2025, with shares trading around $27.13, down roughly 9% on the day after opening near $29.28 and touching an intraday range of about $26.85 to $29.37. Investing.com That kind of drop isn’t usually about one single headline. For refiners like PBF, the market often reacts to a messy cocktail of factors—operational incidents, regulatory scrutiny, and the broader crude/product price backdrop. Today’s flow of reporting fits that pattern, especially with fresh attention on PBF-linked refinery developments and a generally softer tone in energy tied to falling oil
16 December 2025
··
Amgen Stock (AMGN) News Today, Dec. 16, 2025: Dividend Boost, FDA Wins, Analyst Targets, and Key 2026 Catalysts

Amgen Stock (AMGN) News Today, Dec. 16, 2025: Dividend Boost, FDA Wins, Analyst Targets, and Key 2026 Catalysts

Amgen Inc. (NASDAQ: AMGN) is in focus on December 16, 2025, as investors weigh a fresh dividend raise, recent regulatory momentum, and a pipeline narrative that stretches from cardiovascular outcomes to the high-stakes obesity race. As of Dec. 16, 2025 (18:00 UTC), Amgen shares traded around $324.36, slightly lower on the day, with an intraday range roughly between $323.05 and $326.03. While price action is calm, the story around AMGN is busy—especially for long-term investors looking for a blend of income, defensiveness, and late-stage catalysts. What’s driving Amgen stock on Dec. 16: dividends back in the spotlight A key theme
16 December 2025
··
Sanmina Stock (SANM) Slumps on Dec. 16, 2025 After Houston Energy Factory Expansion and Končar Transformer Deal

Sanmina Stock (SANM) Slumps on Dec. 16, 2025 After Houston Energy Factory Expansion and Končar Transformer Deal

Sanmina Corporation (NASDAQ: SANM) stock fell sharply in Tuesday trading, even as the company unveiled two growth-oriented moves aimed at the U.S. power-grid equipment market: a new, state-of-the-art energy-focused factory planned for Houston and a transformer co-design agreement with Croatia’s Končar Group. At last check on Dec. 16, SANM shares were down about 8.85% at $144.17, after swinging between an intraday high of $159.98 and a low of $144.17. The market’s reaction highlights a familiar tension in “build for the future” announcements: investors may like the destination, but they immediately start interrogating the travel budget—capital spending, cash flow timing, and
16 December 2025
·
AbbVie Stock (ABBV) News, Forecasts and Analysis for Dec. 16, 2025: BofA Trims Target as Pipeline Catalysts Stay in Focus

AbbVie Stock (ABBV) News, Forecasts and Analysis for Dec. 16, 2025: BofA Trims Target as Pipeline Catalysts Stay in Focus

AbbVie Inc. (NYSE: ABBV) is trading lower on Tuesday, December 16, 2025, after a strong run earlier in the quarter and a Monday close that kept the stock near the upper end of its 52‑week range. As of 17:54 UTC on Dec. 16, ABBV was at $222.44, down $5.01 (-2.20%) on the session, with an intraday range of $222.44 to $228.00. Today’s AbbVie coverage is being driven less by a single blockbuster headline and more by the familiar mix of Wall Street recalibration and pipeline expectations: Bank of America trimmed its price target, while fresh pipeline-focused analysis reiterated the thesis
16 December 2025
··
Navan (NAVN) Stock Sinks on Q3 Earnings and CFO Exit: Guidance, Analyst Price Targets, and Forecasts for 2026 (Dec. 16, 2025)

Navan (NAVN) Stock Sinks on Q3 Earnings and CFO Exit: Guidance, Analyst Price Targets, and Forecasts for 2026 (Dec. 16, 2025)

Navan, Inc. (NASDAQ: NAVN) stock was one of the market’s sharpest decliners on Tuesday, December 16, 2025, sliding roughly high-teens after the company’s first post-IPO earnings report landed with a thud—and after investors digested news that the company’s CFO plans to step down early next month. Barron’s+1 The selloff is a classic public-market paradox: the operating business is still growing quickly, but the headline numbers and leadership change are triggering early “trust and timing” questions that can hit newly listed stocks especially hard. What’s driving Navan stock today By mid-session, Navan shares were down about 17%–18%, according to multiple market
16 December 2025
·
1 … 1,493 1,494 1,495 1,496 1,497 … 2,716

Stock Market Today

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

7 February 2026
Kenvue shares closed Friday at $18.13, up 0.33%, with about 63.5 million shares traded. The Kimberly-Clark offer values Kenvue at roughly $18.76 per share, leaving a deal spread of about 3%. Both companies’ shareholders approved the merger, which is expected to close in the second half of 2026 pending regulatory approvals. Kenvue’s dividend record date is Feb. 11, with earnings due Feb. 17.
Go toTop